Potential new drug for diabetes

WASHINGTON – In a new study, an experimental oral drug successfully lowered blood sugar levels and inflammation in mice with Type 2 diabetes.

The finding raises hopes that someday the drug could be added to the arsenal of drugs used by millions of people with this …. Source  : Potential new drug for diabetes.

Ranbaxy to launch anti-diabetic drug Actos by 2012

MUMBAI – Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012.

Ranbaxy, majority owned by Japan’s Daiichi Sankyo, said it has settled litigation with the country’s Takeda Pharmaceutical over a generic equivalent version of the medicine and received a non-exclusive royalty free licence for its US patents covering …. Source  : Gaea News Network.

Clarification: Amylin FDA information request story

Clarification: Amylin FDA info request story

SAN DIEGO – In a story March 15, The Associated Press reported that Bydureon is the proposed trade name of exenatide, a diabetes treatment being developed by Amylin Pharmaceuticals Inc., Eli Lilly & Co. and Alkermes Inc. The story should have specified that the once-weekly form of the drug, exenatide … Original article on : Clarification: Amylin FDA information request story.

Selenium may help fight diabetes in men

WASHINGTON – For men, high plasma selenium concentrations are associated with a lower occurrence of dysglycemia, says a new study.

Dysglycemia is any disorder of blood sugar metabolism.
The research has been published in BioMed Central’s open access journal Nutrition and Metabolism.
Tasnime Akbaraly, from the University of Montpellier, worked with a team of researchers to follow 1162 … Read : Selenium may help fight diabetes in men.

Diabetics who have difficulty reaching out to others face early death risk

WASHINGTON – If a new research is to be believed, then being overly cautious or dismissive in relating to people could shorten the lives of people with diabetes.

The five-year study showed that diabetes patients who have a lower propensity to reach out to others have a higher mortality rate than those who feel comfortable seeking … Original article on : Diabetics who have difficulty reaching out to others face early death risk.